Review
Open access
Aug 2026
Clinical Efficacy And Safety Of Baricitinib In Juvenile Idiopathic Arthritis: A Systematic Review And Meta-Analysis Of Randomized And Observational Evidence
Background: Baricitinib is an oral selective Janus kinase 1/2 inhibitor that has recently been evaluated in paediatric juvenile idiopathic arthritis (JIA), a heterogeneous chronic inflammatory disease which merits durable arthritis therapy, flare prevention, maintenance and careful surveillance to ensure safety. This s...
Varnit Kaushik, Aqeel Haider, Prachi Jain et al.
· PAIN, JOINTS, SPINE · 0 citations